Real Option Value and Path Dependence in Oncology Innovation-Reference-Cited by-同舟云学术

Real Option Value and Path Dependence in Oncology Innovation

Published:2011-07 Issue:2 Volume:18 Page:225-238
ISSN:1357-1516
Container-title:International Journal of the Economics of Business
language:en
Short-container-title:International Journal of the Economics of Business

Author:

Cook Joseph P.,Golec Joseph H.,Vernon John A.,Pink George H.

Publisher

Informa UK Limited

Subject

Economics and Econometrics,Business, Management and Accounting (miscellaneous)

Link

http://www.tandfonline.com/doi/pdf/10.1080/13571516.2011.584428

Reference16 articles.

1. Camejo, Rodrigo, McGrath, Clare, and Herings, Ron (2010) A dynamic perspective on pharmaceutical competition, drug development and cost effectiveness,Health Policy. [Epub ahead of print].

2. Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection

3. Pharmaceutical R&D Spending and Threats of Price Regulation

4. Impact of Economic, Regulatory, and Patent Policies on Innovation in Cancer Chemoprevention

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Willingness to pay for an mRNA-based anti-cancer treatment: results from a contingent valuation study in Israel;Israel Journal of Health Policy Research;2024-02-19

2. Strategic flexibility in healthcare: an exploration of real options;Journal of Economic Studies;2024-02-13

3. Estimating the Product Lifecycle Value of Trastuzumab Based on Registry Data in Sweden;Clinical Drug Investigation;2023-07

4. Should We Consider Including a Value for “Hope” as an Additional Benefit Within Health Technology Assessment?;Value in Health;2022-09

5. The Impact of Broader Value Elements on Cost-Effectiveness Analysis: Two Case Studies;Value in Health;2022-08